G2032Rmuta相关论文
SAF-189s,a potent new-generation ROS1 inhibitor,is active against crizotinib-resistant ROS1 mutant-d
The ROS1 fusion kinase is an attractive antitumor target.Though with significant clinical efficacy,the well-known first-......
